That pounding in your head after a long screen day feels unbearable — but is it a migraine or just a headache? Here’s how to ...

Jemma O'Donovan described the discovery as "a complete accident" ...

AbbVie’s Aquipta (atogepant) has been recommended by NICE as an option for the acute treatment of migraine with or without aura in adults, provided patients have previously tried at least two triptans ...

Migraine with aura was associated with an increased risk for incident ischemic stroke in middle-aged adults, with no difference among Black and white patients, according to a study published in ...

Migraine with aura was associated with an increased risk of ischemic stroke in middle-aged and older people, according to a study published, in Neurology. Migraine without aura was not associated with ...

Ever experience ‘word salad’ or jumbled speech during a migraine? Learn why transient aphasia happens, how long it lasts, and ...

Migraine with aura is associated with an increased risk for ischemic stroke in adults aged 45 years or older, according to a ...

MINNEAPOLIS — Migraine with aura was associated with an increased risk of ischemic stroke in middle-aged and older people, according to a study published May 20, 2026, in Neurology ® Open Access, an ...

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the prophylaxis ...

The symptoms of migraine and early brain tumour can sometimes overlap, but subtle differences that can help us identify which ...

Israeli scientists find air pollution exposure tied to a higher risk of migraine attacks.

The decision is supported by results from the Phase III ECLIPSE study, which assessed Aquipta versus placebo for migraine.